Complement C3 inhibition by compstatin Cp40 prevents intra- and extravascular hemolysis of red blood cells.

Baas, Inge; Delvasto-Nuñez, Laura; Ligthart, Peter; Brouwer, Conny; Folman, Claudia; Reis, Edimara S; Ricklin, Daniel; Lambris, John D; Wouters, Diana; de Haas, Masja; Jongerius, Ilse; Zeerleder, Sacha S. (2019). Complement C3 inhibition by compstatin Cp40 prevents intra- and extravascular hemolysis of red blood cells. (In Press). Haematologica - the hematology journal Ferrata-Storti Foundation 10.3324/haematol.2019.216028

[img] Text
haematol.2019.216028.full.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (1MB) | Request a copy

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > Unit Childrens Hospital > Forschungsgruppe Hämatologie (Erwachsene)
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Haematology and Central Haematological Laboratory

UniBE Contributor:

Zeerleder, Sacha Sergio

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0390-6078

Publisher:

Ferrata-Storti Foundation

Language:

English

Submitter:

Pierrette Durand Lüthi

Date Deposited:

23 Sep 2019 09:38

Last Modified:

23 Oct 2019 07:01

Publisher DOI:

10.3324/haematol.2019.216028

PubMed ID:

31171642

Uncontrolled Keywords:

Autoimmune hemolytic anemia Autoimmunity Complement-mediated hemolysis Red Cells

BORIS DOI:

10.7892/boris.133376

URI:

https://boris.unibe.ch/id/eprint/133376

Actions (login required)

Edit item Edit item
Provide Feedback